Arjan B. Brenkman

University Medical Center Utrecht

Papers

1

Total Citations

87

H-Index

1

About

Arjan B. Brenkman is a leading researcher in molecular immunology, with a primary focus on the mechanisms of cytotoxic lymphocyte function and the role of granzymes in immune defense. His work has significantly advanced our understanding of how these serine proteases eliminate virus-infected and tumor cells. In his highly cited 2008 study (87 citations), Brenkman demonstrated that granzyme K (GrK) displays a highly restricted substrate specificity that only partially overlaps with granzyme A (GrA), challenging previous assumptions about functional redundancy among granzymes. This finding was pivotal in establishing GrK as a distinct player in the immune response, with unique molecular targets and mechanisms. Beyond this landmark contribution, Brenkman’s research has explored the broader implications of granzyme activity in immune regulation and disease, earning him recognition as a key figure in the field. His work continues to inform therapeutic strategies for enhancing anti-tumor immunity and controlling viral infections, making him an influential voice for students and researchers interested in the intersection of proteolysis and immunology.

Research Focus

Key Achievements

1
H-Index
1
Papers
87
Total Citations
87
Avg Citations/Paper
🏆 Most Cited Paper
Granzyme K Displays Highly Restricted Substrate Specificity That Only Partially Overlaps with Granzyme A
87 citations · 2008
📈 Most Prolific Year: 2008 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: University Medical Center Utrecht

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago